Vanda Pharmaceuticals, Inc. (VNDA)
6.07
-0.07
(-1.14%)
USD |
NASDAQ |
Dec 09, 16:00
6.11
+0.04
(+0.66%)
After-Hours: 20:00
Vanda Pharmaceuticals Total Assets (Quarterly): 601.14M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.331B |
| ADMA Biologics, Inc. | 568.69M |
| Aldeyra Therapeutics, Inc. | 77.80M |
| Exelixis, Inc. | 2.824B |
| Anavex Life Sciences Corp. | 103.82M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 135.14M |
| Shareholders Equity (Quarterly) | 466.00M |
| Debt to Equity Ratio | 0.0234 |
| Current Ratio | 3.118 |
| Net Debt Paydown Yield | -0.17% |